logo IDIBELL
Català  |   Castellano  |   English
Search
The InstituteResearchWhat's onPlatformsJoin usTools
 

Hematopoyetic and lymphoid tumors


Research lines

Clinical and biological correlations in lymphoid tumors

 

Alloreactivity and chimerism

 

Minimal residual disease

 

New therapeutic targets

 

Infections in neutropenic patients

 

Solid organ post-transplant lymphomas

 

Acute Leukemias

 

Chronic myeloproliferative Syndromes


Selected papers (2012)

 

Sánchez-Ortega I, Vázquez L, Montes C, Patiño B, Arnan M, Bermúdez, A, Yáñez L, Caballero T, Duarte RF.

Effect of Posaconazole on Cyclosporine Blood Levels and Dose

Adjustment in Allogeneic Blood and Marrow Transplant Recipients

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

2012 Dec;56(12):6422-6424

 

Sánchez-Ortega I, Servitje O, Arnan M, Ortí G, Peralta T, Manresa F,Duarte RF.

Dasatinib as salvage therapy for steroid refractory and imatinib resistant or intolerant sclerotic chronic graft-versus-host disease

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 2012

Feb;18(2):318-323

 

Peñate Y, Hernández-Machín B, Pérez-Méndez LI, Santiago F, Rosales, B, Servitje O, Estrach T, Fernández-Guarino M, Calzado L, Acebo E,Gallardo F, Salar A, Izu R, Ortiz-Romero PL, Pujol RM, Fernández-de-Misa R.

Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study.

The Spanish Working Group on Cutaneous Lymphoma

BRITISH JOURNAL OF DERMATOLOGY 2012 Jul;167(1):174-179

 

Robles C, Poloczek A, Casabonne D, Gonzalez-Barca E, Bosch R,Benavente Y, Viscidi RP, de Sanjosé S.

Antibody Response to Merkel Cell Polyomavirus Associated with Incident Lymphoma in the Epilymph Case-Control Study in Spain

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

2012 Sep;21(9):1592-1598

 

Mengual-Chuliá B, García-Pérez R, Gottschling M, Nindl I, Bravo IG.

Novel animal papillomavirus sequences and accurate phylogenetic placement

MOLECULAR PHYLOGENETICS AND EVOLUTION 2012 Dec;65(3):883-91

imatge personal
 

Group leader

Ana Sureda
Telephone  
+34 932607301
E-mail  
asureda@idibell.cat
 
© 2017 Institut d'Investigació Biomèdica de Bellvitge



Results by pageInitial date
Select date
TitleFinal date
Select date
Search


Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept



Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept


Cancell

Passwords doesn’t match
The password must have at least 6 characters
The new password can not contain special characters
User register

Name
Surname
Second Surname
E-mail
User
Password
Language


Accept


Cancell




Encara no heu contestat l'enquesta de satisfacció sobre la píndola formativa sobre patents. No trigareu més de cinc minuts a fer-ho. La vostra opinió és molt important per millorar l’IDIBELL.

Voleu fer l’enquesta ara?

Yes

No




Further personal and contact information is needed to maintain IDIBELL databases.

Do you wish to fill the form now?

Yes

No





Please, remember to introduce your holiday’s planning in the application

Accept

Cancell